Arkolith/Insider Trading/MRKR/Form 4

Eansor Norman David

DirectorMarker Therapeutics, Inc. (MRKR) · full profile →Form 4 · filed Nov 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2025Grant(A)84K—$084K
Nov 17, 2025Grant(A)137K—$0137K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001270905-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML